Strs Ohio Morphic Holding, Inc. Transaction History

Strs Ohio

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$34.33 - $62.11 $247,176 - $447,192	7,200 New	7,200 $412,000
Q1 2022 Apr 21, 2022	SELL	$36.25 - $52.02 $355,250 - $509,796	-9,800 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$53.61 - $67.5 $10,722 - $13,500	-200 Reduced 2.0%	9,800 $555,000
Q2 2021 Jul 26, 2021	SELL	$45.13 - $64.99 $157,955 - $227,464	-3,500 Reduced 25.93%	10,000 $573,000
Q4 2020 Jan 25, 2021	BUY	$25.66 - $34.55 $346,410 - $466,424	13,500 New	13,500 $452,000

Q2 2020 Jul 23, 2020	SELL	$12.65 - $29.57 $16,445 - $38,441	-1,300 Closed	0 $0
Q3 2019 Oct 21, 2019	BUY	$17.46 - $29.05 $22,698 - $37,765	1,300 New	1,300 $23,000

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.2B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.